Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 13, 2026
Rajesh Kumar's Stock Ratings
HSBC Analyst
Rajesh Kumar is an analyst at HSBC. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
4.50%
Smart Score
Overall Average Return Percentile
43rd
Number of Ratings
37
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/06/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $657.83 | 33.77% | $990 → $880 | Maintains | Buy | Get Alert | |
| 07/06/2026 | ZTS | Buy Now | Zoetis | $75.27 | 26.21% | $140 → $95 | Maintains | Buy | Get Alert | |
| 07/06/2026 | PFE | Buy Now | Pfizer | $24.52 | 14.22% | $32 → $28 | Downgrade | Buy → Hold | Get Alert | |
| 06/03/2026 | DHR | Buy Now | Danaher | $199.55 | 15.26% | $270 → $230 | Maintains | Buy | Get Alert | |
| 03/17/2026 | LLY | Buy Now | Eli Lilly | $1.19K | -28.44% | $1070 → $850 | Downgrade | Hold → Reduce | Get Alert | |
| 03/17/2026 | PFE | Buy Now | Pfizer | $24.52 | 30.53% | $29 → $32 | Maintains | Buy | Get Alert | |
| 03/17/2026 | BIIB | Buy Now | Biogen | $202.56 | -25.95% | $143 → $150 | Maintains | Reduce | Get Alert | |
| 03/17/2026 | BMY | Buy Now | Bristol-Myers Squibb | $58.67 | 2.26% | $53 → $60 | Maintains | Hold | Get Alert | |
| 12/10/2025 | BIIB | Buy Now | Biogen | $202.56 | -29.4% | $144 → $143 | Downgrade | Hold → Reduce | Get Alert | |
| 12/10/2025 | ABBV | Buy Now | AbbVie | $246.15 | 7.66% | $225 → $265 | Upgrade | Hold → Buy | Get Alert | |
| 11/24/2025 | NVO | Buy Now | Novo Nordisk | $49.59 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 10/09/2025 | IQV | Buy Now | IQVIA Hldgs | $209.91 | 11.95% | $195 → $235 | Upgrade | Hold → Buy | Get Alert | |
| 10/02/2025 | NVO | Buy Now | Novo Nordisk | $49.59 | 41.16% | → $70 | Upgrade | Hold → Buy | Get Alert | |
| 10/01/2025 | ABBV | Buy Now | AbbVie | $246.15 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 08/27/2025 | LLY | Buy Now | Eli Lilly | $1.19K | -41.07% | $675 → $700 | Upgrade | Reduce → Hold | Get Alert | |
| 07/31/2025 | NVO | Buy Now | Novo Nordisk | $49.59 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 04/28/2025 | LLY | Buy Now | Eli Lilly | $1.19K | -41.07% | $1150 → $700 | Downgrade | Buy → Reduce | Get Alert | |
| 04/25/2025 | KDP | Buy Now | Keurig Dr Pepper | $31.68 | 32.58% | $36 → $42 | Upgrade | Hold → Buy | Get Alert | |
| 04/25/2025 | IQV | Buy Now | IQVIA Hldgs | $209.91 | -23.78% | $260 → $160 | Downgrade | Buy → Hold | Get Alert | |
| 06/05/2024 | ABBV | Buy Now | AbbVie | $246.15 | -24.84% | → $185 | Upgrade | Hold → Buy | Get Alert | |
| 04/30/2024 | TMO | Buy Now | Thermo Fisher Scientific | $530.01 | 26.41% | $660 → $670 | Maintains | Buy | Get Alert | |
| 04/17/2024 | TMO | Buy Now | Thermo Fisher Scientific | $530.01 | 24.53% | $630 → $660 | Maintains | Buy | Get Alert | |
| 04/17/2024 | DHR | Buy Now | Danaher | $199.55 | 40.32% | $250 → $280 | Upgrade | Hold → Buy | Get Alert | |
| 04/04/2024 | UNH | Buy Now | UnitedHealth Group | $428.16 | 7.44% | → $460 | Upgrade | Reduce → Hold | Get Alert | |
| 12/18/2023 | DHR | Buy Now | Danaher | $199.55 | — | — | Initiates | → Hold | Get Alert | |
| 12/18/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $32.73 | -60.28% | → $13 | Initiates | → Buy | Get Alert | |
| 12/18/2023 | TMO | Buy Now | Thermo Fisher Scientific | $530.01 | 15.09% | → $610 | Initiates | → Buy | Get Alert | |
| 12/18/2023 | ABBV | Buy Now | AbbVie | $246.15 | -36.62% | $167 → $156 | Downgrade | Buy → Hold | Get Alert | |
| 12/18/2023 | UNH | Buy Now | UnitedHealth Group | $428.16 | 12.11% | $550 → $480 | Downgrade | Hold → Reduce | Get Alert | |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.67 | -9.67% | $55 → $53 | Upgrade | Reduce → Hold | Get Alert | |
| 07/14/2023 | MRNA | Buy Now | Moderna | $68.92 | 40.75% | → $97 | Initiates | → Reduce | Get Alert | |
| 07/14/2023 | BNTX | Buy Now | BioNTech | $91.74 | 35.16% | → $124 | Initiates | → Buy | Get Alert | |
| 07/14/2023 | PFE | Buy Now | Pfizer | $24.52 | 103.96% | → $50 | Initiates | → Buy | Get Alert | |
| 07/14/2023 | MRK | Buy Now | Merck & Co | $123.84 | -0.68% | → $123 | Initiates | → Hold | Get Alert | |
| 07/14/2023 | LLY | Buy Now | Eli Lilly | $1.19K | -52.86% | → $560 | Initiates | → Buy | Get Alert | |
| 07/14/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.67 | -4.56% | → $56 | Initiates | → Reduce | Get Alert | |
| 07/14/2023 | ABBV | Buy Now | AbbVie | $246.15 | -32.16% | → $167 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved